A Texas-based compounding company is pulling six lots of injectable "wellness" supplements off the market nationwide after testing found they contained elevated levels of bacterial toxins, and the FDA warns the contaminated products could cause anaphylactic shock or death.
Centric Compounding voluntarily recalled three injectable products marketed for immunity, fatigue, and "general wellness" after discovering that the glutathione ingredient used to make them carried elevated endotoxin levels. Endotoxins are toxic molecules shed by bacteria such as E. coli and Salmonella. Injecting them directly into the bloodstream can trigger a severe immune response.
The FDA did not hold back about the risk. In its recall statement, the agency said there is a "reasonable probability" that the contaminated products could cause fevers, dangerously low blood pressure, inflammatory reactions, anaphylactic shock, and death.
Nine people have already reported adverse reactions to Centric Compounding, including fever, chills, chest pain, nausea, vomiting, headache, and general malaise. The company distributed the products nationwide, shipped directly to patients' homes and delivered to prescribers, meaning the potential exposure stretches well beyond Texas.
The recall covers six lots of three separate injectable products, all packaged in 30-milliliter vials:
Anyone who has these products at home should stop using them immediately and throw them away, the FDA said. The agency added that anyone who develops a fever above 102 degrees Fahrenheit after receiving one of the injections should seek emergency medical care.
Centric Compounding said it is notifying distributors and customers by email and arranging to replace all recalled products.
Beyond the immediate contamination risk, the FDA flagged a broader concern: it has not reviewed or approved any injectable glutathione product for safety or effectiveness. That means consumers who received these shots were trusting a product that has never cleared the standard federal approval process, and were injecting it directly into their bodies.
Glutathione supplements have gained popularity in recent years, marketed as antioxidants with supposed anti-aging and immune-boosting benefits. The FDA's recall notice described the recalled products simply as items "used to support immunity, fatigue and general wellness." Medical organizations, though none were named in the recall, have cautioned against the off-label use of injectable glutathione.
Compounding pharmacies occupy a gray zone in American drug regulation. They mix custom formulations that are not subject to the same pre-market approval required of mass-manufactured drugs. That flexibility can serve patients with legitimate needs. But it also means consumers can end up injecting products that have never been independently tested for safety, and, as this recall shows, may contain dangerous contaminants.
The recall notice leaves significant gaps. It does not explain how the elevated endotoxin levels were discovered, whether through routine internal testing, a patient complaint, or an outside inspection. It does not identify the supplier of the contaminated glutathione ingredient. And it does not say whether any of the nine reported adverse events led to hospitalization or serious injury.
The FDA also did not disclose the recall's classification level, a detail that would signal how seriously the agency rates the health threat. Nor did it name the specific lot numbers, which would help patients and prescribers verify whether their supply is affected.
Centric Compounding says it will replace the recalled products, but the company has not said whether the replacements will use a different source for the glutathione ingredient, a basic question for anyone weighing whether to trust a second round from the same manufacturer.
When a company ships injectable products contaminated with bacterial toxins into patients' homes across the country, "voluntary recall" and a follow-up email are the bare minimum, not proof the system worked.